Arthur Herbst to Maternal-Fetal Exchange
This is a "connection" page, showing publications Arthur Herbst has written about Maternal-Fetal Exchange.
Connection Strength
0.379
-
Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
Score: 0.050
-
Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
Score: 0.043
-
Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
Score: 0.042
-
Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
Score: 0.042
-
Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol. 1972 Sep; 40(3):287-98.
Score: 0.027
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
Score: 0.025
-
Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspect. 2007 Sep; 115(9):1314-9.
Score: 0.019
-
The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
Score: 0.018
-
Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
Score: 0.013
-
A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med. 1980 Feb; 24(2):62-9.
Score: 0.011
-
DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
Score: 0.011
-
A correlative nuclear DNA and histologic study of genital squamous lesions in DES exposed progeny. Obstet Gynecol Surv. 1979 Nov; 34(11):849-50.
Score: 0.011
-
Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
Score: 0.010
-
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
Score: 0.009
-
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
Score: 0.009
-
Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
Score: 0.008
-
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
Score: 0.008
-
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
Score: 0.007
-
Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
Score: 0.006
-
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
Score: 0.002
-
Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
Score: 0.002
-
Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
Score: 0.002
-
Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
Score: 0.002